| Serial Number | 97596410 |
| Word Mark | MOPED |
| Filing Date | Monday, September 19, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Monday, August 12, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 19, 2023 |
| Goods and Services | Downloadable computer software for drug discovery, screenings, and providing pharmaceuticals; downloadable computer software for use to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry, clinical trial management and patient engagement |
| Goods and Services | Drug discovery services; DNA and protein screening for scientific research purposes; Platform as a service (PAAS) featuring computer software platforms for drug discovery, screenings, and providing pharmaceuticals; Scientific and technological services and research and design, namely, research and design in the field of drug discovery and DNA and protein screening; Scientific research and development in the field of analysis of technical data by computers; pharmaceutical drug discovery services; research and development in the pharmaceutical and biotechnology fields; drug discovery services and research and development in the pharmaceutical drug use field; design and development of pharmaceutical preparations and medicines; scientific research and development in the field of drug discovery; scientific research and development in the nature of conducting scientific and pharmaceutical research and data analysis to screen for and identify molecular interactions, compounds and detect toxicity; providing scientific, pharmaceutical and agrochemical database research services; scientific research and development in the nature of scientific and pharmaceutical artificial intelligence research services to identify molecules and compounds for drug discovery and chemical development; scientific research and development in the nature of bioinformatics services for using the combination of biology, computer science, information engineering, mathematics and statistics to analyze and interpret biological data; scientific research and development in the nature of computer assisted molecule design; scientific research and development in the nature of identification of biological targets, networks and pathways; biological research and analysis; pharmaceutical research and development services; computer aided diagnostic and DNA and protein screening services for scientific research purposes; scientific research and development in the nature of contract research services in support of scientific research and development of pharmaceutical preparations; Software as a service (SaaS) services featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; Software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; Software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 4, 2022 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 4, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Oncopia Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10036 |
| Party Name | Oncopia Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10036 |
| Event Date | Event Description |
| Thursday, September 22, 2022 | NEW APPLICATION ENTERED |
| Tuesday, October 4, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, June 29, 2023 | ASSIGNED TO EXAMINER |
| Friday, July 7, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, July 7, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, July 7, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, October 5, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, October 5, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 5, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, November 14, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, November 14, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, November 14, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, November 14, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, November 14, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 29, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 19, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 19, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 13, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, August 12, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, August 12, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 12, 2024 | SOU EXTENSION 1 GRANTED |
| Monday, August 12, 2024 | SOU EXTENSION 1 FILED |
| Thursday, January 23, 2025 | SOU TEAS EXTENSION RECEIVED |